Changeflow GovPing Healthcare Medline Recall: Dialysis Kits with Tego Connect...
Urgent Enforcement Removed Final

Medline Recall: Dialysis Kits with Tego Connector Seal Defects

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 4th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has initiated a Class II recall for Medline Kits containing Tego Connectors (SKU EBSI1746) due to defects in the silicone seal, which can cause occlusion. The recall impacts nationwide distribution in the US. The recall is ongoing.

What changed

The FDA has classified a recall of Medline Kits containing Tego Connectors (SKU EBSI1746) as Class II due to issues with the silicone seal, including doming and tearing. These defects can lead to an occluded fluid path, preventing users from injecting or withdrawing blood products with a syringe. The affected product has seen nationwide distribution within the US.

Healthcare providers and medical device manufacturers should be aware of this recall and take appropriate action regarding affected inventory. While the document does not specify a compliance deadline, the nature of a device recall necessitates immediate attention to product management and patient safety. Failure to address device defects can lead to patient harm and regulatory scrutiny.

What to do next

  1. Review inventory for Medline DIALYSIS ON/OFF KIT (SKU EBSI1746).
  2. Quarantine and remove affected kits from service.
  3. Follow Medline's specific instructions for product return or disposition.

Source document (simplified)

Medline Industries, LP

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1464-2026 · 20260304 · Ongoing

Product

Medline Kits containing Tego Connectors Medline DIALYSIS ON/OFF KIT SKU EBSI1746

Reason for Recall

Affected lots may exhibit issues with the silicone seal on Tego Connectors included in kits. Issues include silicone seal doming and silicone seal tearing. These issues may result in an occluded fluid path identified by the inability of the user to inject or withdraw blood product with a syringe....

Distribution

US Nationwide distribution.

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 4th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1464-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recalls Product Safety
Threshold
Class II
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Product Safety Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.